DJ

Devangiben Jigneshkumar Shah

Active Director Whole-Time Director DIN 09303600
DIN 09303600 First appointment Sep 2021 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 3 active board seats
Past companies 1 historical roles
Total affiliations 4 Since Sep 2021
Shareholding value •••• Premium profile

About Devangiben Jigneshkumar Shah

Data last updated:

Devangiben Jigneshkumar Shah is a Whole-Time Director at Asons Pharmaceuticals Private Limited (since 2021), Director at Purecaps India Private Limited (since 2021) and Director at Asons Biotech Private Limited (since 2023). The companies operate in Pharma and Agriculture. The 2 current companies with reported revenue have a combined latest revenue of ₹32.73 Cr; the largest is Asons Pharmaceuticals Private Limited at ₹32.40 Cr (FY 2025). Earlier, Devangiben Jigneshkumar Shah was an Additional Director at Astral Steritech Private Limited (from 2025).

DIN 09303600
Primary Designation Whole-Time Director
Industry Pharma
First Appointment 02 Sep 2021
Oldest Company Age 14 yrs
Largest company Asons Pharmaceuticals Private Limited · ₹32.40 Cr (FY 2025)
Combined revenue ₹32.73 Cr across 2 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Whole-Time Director02 Sep 20212021₹32.40 Cr (FY 2025)Active
Purecaps India Private Limited U24239GJ2021PTC125836
Director20 Nov 20212021₹33.3 Lakh (FY 2025)Active
Asons Biotech Private Limited U47737GJ2023PTC140648
Director28 Apr 20232023Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Astral Steritech Private Limited U24100GJ2012PTC071810
Additional Director09 Jun 20252012₹202 Cr (FY 2022)Under Cirp

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Purecaps India Private Limited
Asons Pharmaceuticals Private Limited
Astral Steritech Private Limited
Asons Biotech Private Limited
Premium access

Shareholding and investment profile for Devangiben Jigneshkumar Shah

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Devangiben Jigneshkumar Shah

Devangiben Jigneshkumar Shah currently holds 3 directorships: Asons Pharmaceuticals Private Limited (Whole-Time Director, since 02 Sep 2021, revenue ₹32.40 Cr (FY 2025)); Purecaps India Private Limited (Director, since 20 Nov 2021, revenue ₹33.3 Lakh (FY 2025)); Asons Biotech Private Limited (Director, since 28 Apr 2023).

Devangiben Jigneshkumar Shah was first appointed on 02 Sep 2021 as Whole-Time Director at Asons Pharmaceuticals Private Limited. The most recent appointment on record is 09 Jun 2025 at Astral Steritech Private Limited.

The 2 current companies of Devangiben Jigneshkumar Shah that report revenue have a combined latest revenue of ₹32.73 Cr: Asons Pharmaceuticals Private Limited ₹32.40 Cr (FY 2025); Purecaps India Private Limited ₹33.3 Lakh (FY 2025).

Devangiben Jigneshkumar Shah held 1 earlier board appointment: Astral Steritech Private Limited (Additional Director, from 09 Jun 2025).

The current boards of Devangiben Jigneshkumar Shah's companies include Jigneshkumar Ashvinbhai Shah (Asons Pharmaceuticals Private Limited), Kiran Mohanlal Jain (Asons Pharmaceuticals Private Limited), Uttamkumar Mohanlal Jain (Asons Pharmaceuticals Private Limited), Ronit Kirankumar Jain (Purecaps India Private Limited), Samkitkumar Jain (Purecaps India Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available